Status:
COMPLETED
Digi-Do - a Digital Information Tool to Help Patients Diagnosed With Breast Cancer
Lead Sponsor:
Jonkoping University
Conditions:
Breast Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This project uses participatory design combined with qualitative and quantitative methods to develop, explore and evaluate the usefulness of a digital information tool to prepare and support patients ...
Detailed Description
The study is a prospective and longitudinal Randomised Control Trial (RCT) study with an Action Research (AR) participatory design approach, including mixed-method data collection, i.e., standardised ...
Eligibility Criteria
Inclusion
- Adult patients (\>18 years):
- diagnosed with breast cancer, stage I-II not receiving adjuvant or neo-adjuvant chemotherapy or anti-Her-2 treatment and
- with RT as additional treatment after surgery.
- ability to read, write and understand Swedish enough to adhere to the digital information tool and the applied instruments.
- that have access to a smartphone.
Exclusion
- not receiving RT have had RT before
- diagnosed with dementia
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04394325
Start Date
September 1 2020
End Date
November 30 2023
Last Update
December 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sahlgrenska universitetssjukhuset
Gothenburg, Sweden, 41345